Search
forResearch 10 of 1000+
- miR-761-hepcidin/Gpx4 pathway contribute to unexplained liver dysfunction in polycystic ovary syndrome by regulating liver iron overload and ferroptosis
- Regulation of Epidermal Ferritin Expression Influences Systemic Iron Homeostasis
- S3507 GI Bleed Leading to Discovery of Hereditary Hemochromatosis
- Polycystic ovary syndrome and iron overload: biochemical link and underlying mechanisms with potential novel therapeutic avenues
- The Mask Mutation Identifies TMPRSS6 as an Essential Suppressor of Hepcidin Gene Expression, Required for Normal Uptake of Dietary Iron.
- Protoporphyrin IX: the Good, the Bad, and the Ugly
- Health consequences of anabolic steroids: a sexual-medicine perspective
- Hepatotoxicity Associated with Anabolic Androgenic Steroids and Selective Androgen Receptor Modulators: A Literature Review
- Matriptase-2, A Novel Suppressor of Hepcidin.
- The association between serum ferritin and 25-hydroxyvitamin D and metabolic syndrome in Korean women: the Korea National Health and Nutrition Examination Survey 2010–2012
Community 10 of 86
- Deciding Between Oral or Topical Min and Fin with Fatty Liver
- Increased liver enzymes from hairloss medications.
- Can liver problems be associated with response to the oral minoxidil?
- Sensitive liver, topical fin safe to try?
- Attention Finasteride / Dutasteride and Your liver
- liver problem from finasteride/dutasteride
- 28M: Can I Combine Oral and Topical Finasteride with Elevated Liver Enzymes?
- Could fatty liver(other issues related to it..)play a role in Dupa/Aga?
- ‘Long term use of fin/dut may be associated with health risks including fatty liver disease, insulin resistance, type 2 diabetes, dry eye disease and potential kidney disease.’
- Finally live! alcohol-free, propylene glycol–free topical finasteride foam
Learn
— no results
Try a deeper search in learn →